Type · Diagnostic Questioning

How to Pass the Galapagos Sales Interview in 2026
The Galapagos DNA (TL;DR)
The Galapagos Interview Loop
Your onsite loop will typically consist of 5 rounds.
- 1
Round 1
Recruiter ScreenMotivation, territory fit, logistics. - 2
Round 2
Sales Pitch / DemoPitching the company's product to a mock prospect. - 3
Round 3
Deal StrategyPipeline management, multi-stakeholder navigation, MEDDIC qualification. - 4
Round 4
Customer DiscoveryAsking diagnostic questions, surfacing pain, qualifying. - 5
Round 5
Behavioral / LeadershipPast evidence of ownership, influence, resolving conflict.
The Danger Zone: Top Reasons Candidates Fail
Based on our database of Galapagos interview outcomes, avoid these common traps:
- Vague description of pipeline management without specific tools or methodologies.
- Confusing the 'Economic Buyer' with the 'Champion' or 'Decision Criteria' with 'Decision Process'.
- Blaming others or external factors for the failure.
- Focusing only on their own perspective without acknowledging others.
Test Yourself: Real Galapagos Questions
Three real prompts pulled from our database.
Type · Objection Handling
Type · Ownership
+ many more questions, signals, and worked examples
Sign up to unlock the full Galapagos grading rubric
Galapagos Interview Question Bank
A sample from our database, grouped by round. Sign up to see the full set.
9 of 14 questions shown
Recruiter Screen
1- 1
Type · Motivation
Why are you interested in a sales role at Galapagos specifically, and what excites you about our therapeutic areas and pipeline?
Sales Pitch / Demo
2- 2
Type · Product Pitch
Imagine you are speaking with a key opinion leader (KOL) in rheumatology. Pitch Galapagos's flagship product in rheumatoid arthritis (RA), highlighting its unique value proposition and how it addresses unmet needs. - 3
Type · Objection Handling
During your RA product pitch, the KOL says, 'I'm concerned about the long-term safety profile compared to existing biologics.' How do you respond?
Deal Strategy
3- 4
Type · Pipeline Management
Describe your process for managing your sales pipeline. How do you prioritize opportunities, and what metrics do you use to forecast sales? - 5
Type · Multi-stakeholder Navigation
In a hospital setting, multiple stakeholders (physicians, pharmacists, formulary committees, nurses) influence prescribing decisions. How do you navigate these complex stakeholder groups to gain formulary approval and drive adoption for a new therapy? - + 1 more questions in this round (sign up to unlock)
Customer Discovery
3- 6
Type · Diagnostic Questioning
You're meeting a new physician who is currently prescribing a competitor's drug for a specific indication. What are your initial diagnostic questions to understand their current prescribing habits and potential openness to a new therapy? - 7
Type · Surfacing Pain
A physician mentions that their patients are experiencing 'suboptimal responses' with current treatments for a particular condition. How do you probe deeper to uncover the specific pain points and quantify the impact? - + 1 more questions in this round (sign up to unlock)
Behavioral / Leadership
5- 8
Type · behavioral
Tell me about a time you had a disagreement with a colleague or stakeholder regarding a technical decision or project direction. How did you handle the situation, and what was the resolution? - 9
Type · Ownership
Tell me about a time you faced a significant setback in achieving a sales target. What steps did you take to understand the root cause and what was the outcome? - + 3 more questions in this round (sign up to unlock)
Unlock all 14 Galapagos questions, free
No credit card. Every question with its framework, the grading signals interviewers score against, and a worked answer for each.
Interview tracks at Galapagos
How Galapagos's DNA translates across functions. Pick your role.
Compare Galapagos with similar employers
Same DNA, different bar. Browse the closest companies in our database and see how their loops differ.
Merck KGaA
Same tierMerck KGaA seeks candidates demonstrating scientific rigor, innovative problem-solving, and strong collaborative skil...
See Merck KGaA interview questions
AstraZeneca
Same tierAstraZeneca seeks candidates demonstrating scientific rigor, patient-centric innovation, and collaborative problem-so...
See AstraZeneca interview questions
Boehringer Ingelheim
Same tierThey assess scientific rigor and strategic thinking, looking for candidates who can connect research to patient outco...
See Boehringer Ingelheim interview questions
Practice Galapagos interviews end-to-end
Galapagos Mock Interview
Run a live mock interview with our AI interviewer using Galapagos-style prompts. Get scored on structure, signal, and answer length - exactly how the real loop grades you.
Open
STAR Stories for Galapagos Behavioral Rounds
Build a Story Bank of your past wins, mapped to the leadership signals Galapagos interviewers grade on. Reuse them across every behavioral round.
Open
Galapagos Interview Prep Hub
The frameworks behind every Galapagos round: CIRCLES for product sense, hypothesis-driven debugging for analytical, STAR for behavioral. Learn each one in 10 minutes.
Open
Interview Frameworks
CIRCLES, STAR, AARRR, RICE, MECE. The exact frameworks that make Galapagos interviewers nod instead of frown. Step-by-step playbooks with the moves and the pitfalls.
Open
Sample answers
What a strong answer to these Galapagos interview questions shows.
You're meeting a new physician who is currently prescribing a competitor's drug for a specific indication. What are your initial diagnostic questions to understand their current prescribing habits and potential openness to a new therapy?
A strong answer shows: Asks open-ended questions (e.g., 'What factors influence your choice of therapy for this condition?').; Seeks to understand the physician's rationale and experience with current treatments.; Focuses on patient outcomes and unmet needs.; Demonstrates active listening and builds rapport..
During your RA product pitch, the KOL says, 'I'm concerned about the long-term safety profile compared to existing biologics.' How do you respond?
A strong answer shows: Acknowledges and validates the KOL's concern.; Responds with relevant clinical data or insights into ongoing safety studies.; Re-frames the safety profile in the context of efficacy and patient benefit.; Maintains a collaborative and consultative tone..